Skip to main content

Table 3 [18F]FDG PET parameters and TTP.  Univariate analysis of PET1, PET2 and ΔPET for TTP in the full study population (bone + soft tissue sarcoma)

From: [18F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial

 

HR

95% CI

p value

Lower

Upper

PET1-SUVmax

1.10

0.99

1.22

0.061

PET1-SUVmean

1.15

0.86

1.53

0.346

PET1-SUVpeak

1.12

0.99

1.25

0.066

PET1-MTV

1.00

0.99

1.00

0.810

PET1-TLG

1.00

0.99

1.00

0.460

PET2-SUVmax

1.30

1.12

1.51

0.001

PET2-SUVmean

1.76

1.26

1.46

0.001

PET2-SUVpeak

1.38

1.14

1.66

0.001

PET2-MTV

1.00

1.00

1.01

0.020

PET2-TLG

1.00

1.00

1.01

0.019

ΔSUVmax

1.01

0.99

1.02

0.131

ΔSUVmean

1.01

0.99

1.02

0.123

ΔSUVpeak

1.01

0.99

1.02

0.108

ΔMTV

1.01

0.99

1.02

0.146

ΔTLG

1.00

1.00

1.01

0.127